SADC Pharmaceutical Pooled Procurement Charter Signed in Durban
November 13, 2026
SADC pharmaceutical pooled procurement took a formal step on 12 November 2026, when the Charter establishing the SADC Pharmaceuticals Pooled Procurement Services (SPPS) was signed at the regional health ministers’ meeting in Durban. The United Republic of Tanzania became the first Member State to sign it. The SPPS is to operate as an institution of subsidiarity of SADC.
The Ministers of Health and Ministers Responsible for HIV and AIDS met in Durban from 9 to 12 November 2026. The meeting also covered HIV and AIDS, tuberculosis, malaria, sustainable health financing, local pharmaceutical manufacturing, and food and nutrition security. Dr Phaahla also drew attention to the Ebola outbreak in the DRC, alongside cholera and mpox. Deputy Minister of Health Dr Mathume Joseph Phaahla, who chaired the meeting, said: “Our future cannot rest on the goodwill of others alone; it must be built on domestic investment, strong institutions, productive capacity and sustained political commitment.”
How SADC pharmaceutical pooled procurement is meant to work
The source describes the SPPS as a regional mechanism for joint procurement of medicines and health commodities. It is expected to strengthen regional cooperation in pharmaceutical procurement, improve access to affordable and quality-assured medicines, make the supply chain more secure and contribute to the Region’s pharmaceutical self-reliance. Five countries were identified in the programme for signing commitments to take part in the Group Contracting mechanism: South Africa, Mozambique, Lesotho, Seychelles and the United Republic of Tanzania.
Why it matters
The source gives the SPPS’s aims in general terms and carries no pricing, budget, tender volume or start date. The effect of the Charter on what member states pay for medicines cannot be judged from this text. For health technology assessment teams, the open question is how Group Contracting would feed into national listing and reimbursement decisions. The source names the five countries but does not say how medicines would be selected under the mechanism.
Let Google know we are your trusted source.
Add our editorial as a preferred source in your search results.
Value Science Weekly
The week in health technology assessment, market access and health economics — what moved, and what it means.